Physician profile
John J Gribar
NPI 1770600462
$1,640.39
in general payments reported to CMS, 2019-2025
22 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $49.61 · 2021: $41.53 · 2022: $356 · 2023: $233 · 2024: $280 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,075.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $391.96 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Inari Medical, INC. | $279.93 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $244.95 | 2025 | Artix Mt, Flowtriever, Ct Thrombectomy System Kit |
| Abiomed | $171.06 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $67.33 | 2019-2022 | |
| Cardiva Medical, INC. | $52.01 | 2023 | Cardiva Vascade 6/7f Vcs |
| Bard Peripheral Vascular, INC. | $50.99 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| W. L. Gore & Associates, INC. | $36.23 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Amarin Pharma, INC. | $35.79 | 2019-2020 | |
| Becton, Dickinson and Company | $35.74 | 2025 | Rotarexs 6 F X 135 Cm |
| Terumo Medical Corporation | $35.73 | 2023-2025 | Angio-Seal, Tr Band |
| Chiesi USA, INC. | $31.92 | 2024 | Kengreal, Cleviprex |
| E.R. Squibb & Sons, L.L.C. | $28.13 | 2019-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $25.85 | 2019-2020 | |
| Abbott Laboratories | $24.25 | 2024 | Esprit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $23.88 | 2024 | (Br5) Peripheral Ivus |
| Cardinal Health 200 LLC | $22.86 | 2019 | |
| Acist Medical Systems, INC. | $20.06 | 2024 | |
| Shockwave Medical, INC | $17.94 | 2022 | |
| Teleflex LLC | $17.18 | 2022 | |
| Cardiovascular Systems INC. | $15.40 | 2019 | |
| Penumbra, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gribar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.